best results with tirzepatide Before and after weight loss results: what real transformations look like and what determines success Almost to goal! Before and
Description
Rybelsus was approved in 2019 as the first oral semaglutide for type 2 diabetes

Semaglutide, a glucagon like peptide-1 (GLP-1) receptor agonist, is available as monotherapy in both subcutaneous as well as oral dosage form (first approved oral GLP-1 receptor agonist)

Understanding the mechanisms, potential benefits, and side effects of this dual-therapy approach helps inform conversations with your healthcare provider about wei

60mg / 2.4ml

See the full tirzepatide dosage chart for weight loss, from the 2.5 mg starting dose to the 15 mg max

Results At week 72, tirzepatide treatment was associated with significantly larger improvements than placebo in the SF-36v2 Physical Component Summary score, SF-36v2 physical functioning, bodily pain, general health, vitality, and social functioning domain scores, all IWQOL-Lite-CT scores, and EQ VAS score
